Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
Status:
Withdrawn
Trial end date:
2018-08-20
Target enrollment:
Participant gender:
Summary
This study explores the effect of zoledronic acid on incident vertebral fractures and
osteonecrotic lesions in children recently diagnosed with acute lymphoblastic leukemia.